Gastroenterology Research, ISSN 1918-2805 print, 1918-2813 online, Open Access
Article copyright, the authors; Journal compilation copyright, Gastroenterol Res and Elmer Press Inc
Journal website https://www.gastrores.org

Original Article

Volume 16, Number 2, April 2023, pages 92-95

Quality of Capsule Endoscopy Reporting in Patients Referred for Double Balloon Enteroscopy

Figure

Figure 1.
Figure 1. Flowsheet of final capsule report count. A total of 209 DBEs were performed. Of those, 68 patients had no capsule report in the electronic medical record and 12 patients had repeat DBE without repeat VCE. One patient who had repeat DBE had a private practice VCE and a second VCE at an academic center prior to second DBE. A total of 129 capsule reports were analyzed, 45 academic practice and 84 private practice. VCE: video capsule endoscopy; DBE: double balloon enteroscopy.

Tables

Table 1. Report Variables Based on Canadian Consensus Guidelines of Endoscopy Reporting as Adapted by the AGA (2017)
 
AGA: American Gastroenterological Association; GI: gastrointestinal.
Pre-procedure
  Capsule system used
  Date and time of procedure
  Name of reader of capsule output
  Patient demographics
  Indication for capsule
  Previous investigations
  Comorbidities
  Type of bowel preparation
  Allergies
  Medications/anti-spasmodic given
  Information provided to patient/family
Post-procedure
  Quality of bowel preparation
  Extent and completeness of examination
  Key times of entry into portions of GI tract
  Relevant findings
  Pertinent negatives
  Adverse events
  Resulting interventions
  Diagnosis
  Management recommendations

 

Table 2. Presence of Report Variables Among VCE Reports
 
All capsules (n = 129)Private practice (n = 84)Academic centers (n = 45)P value
*P < 0.05. VCE: video capsule endoscopy; GI: gastrointestinal.
Presence of capsule name, n (%)91 (70.5)73 (86.9)18 (40.0)< 0.001*
Indication for capsule, n (%)129 (100)84 (100)45 (100)0
Date and time, n (%)129 (100)84 (100)45 (100)0
Name of reader, n (%)125 (96.9)80 (95.2)45 (100)0.14
Previous investigations, n (%)59 (45.7)33 (39.3)26 (57.8)0.045*
Comorbidities, n (%)28 (21.7)15 (17.9)13 (28.9)0.15
Type of preparation used, n (%)5 (3.8)3 (3.6)2 (4.4)0.81
Medications administered, n (%)32 (24.8)7 (8.3)25 (55.6)< 0.001*
Allergies, n (%)0 (0)0 (0)0 (0)0
Communication to patient/team, n (%)27 (20.9)10 (11.9)17 (37.8)0.001*
Quality of bowel preparation, n (%)30 (23.2)22 (26.2)8 (17.8)0.28
Extent of examination, n (%)97 (75.1)57 (67.9)40 (88.9)0.009*
Key times of entry into GI tract, n (%)113 (87.6)71 (84.5)42 (93.3)0.15
Key findings, n (%)127 (98.4)82 (97.6)45 (100)0.3
Pertinent negatives, n (%)76 (58.9)41 (48.8)35 (77.8)0.002*
Adverse events, n (%)21 (16.2)2 (2.4)19 (42.2)< 0.001*
Diagnosis, n (%)119 (92.2)75 (89.3)44 (97.8)0.087
Management recommendations, n (%)119 (92.2)75 (89.3)44 (97.8)0.087